Please login to the form below
physicians
This page shows the latest physicians news and features for those working in and with pharma, biotech and healthcare.
AZ nabs US approval for new leukaemia drug Lumoxiti
Moxetumomab pasudotox represents a promising non-chemotherapeutic agent for HCL, addressing an unmet medical need for physicians and their patients.”.
Latest news
-
Daily Brief: Jazz Pharma and Ultragenyx approvals, Autonomous AI in retinopathy
Kakkis, M.D., Ph.D., CEO and President of Ultragenyx. “This would not have been possible without the commitment and dedication of the patients, their families, and the physicians who participated ... That's why it was so important for us to develop an
-
Daily Brief: setback for Akcea/Ionis, Urovant adds gene therapy, Metrion gains funding
FCS is an ultra-rare and debilitating disease. Our disappointment extends to the patient and physician community who currently do not have a treatment available to them.
-
Inside the patient-centricity bubble
Patients are pushing us harder, demanding a new relationship, not only physicians but with the industry too.”. ... Thanks to this service, patients can contact a dedicated physician or health coach who encourages individuals to follow a diet consisting
-
AbbVie’s blockbuster-in-waiting for endometriosis gets FDA nod
Women with endometriosis may undergo multiple medical treatments and surgical procedures seeking pain relief and this approval gives physicians another option for treatment based on a woman's specific type and
-
Allergan’s abicipar matches AMD blockbuster Lucentis in phase III
physicians, Regeneron has also been developing a 12-week dosing schedule for its drug that is on course for an FDA verdict next month.
More from news
Approximately 15 fully matching, plus 1,026 partially matching documents found.
Latest Intelligence
-
Cannes Lions Healthcare Agency of the Year – championing change and demanding more…
We also need to recognise the evolution in their characteristics. Today’s physician is more open to collaboration, many of them now harbour entrepreneurial tendencies where their predecessors did not and,
-
Trust me, I’m from pharma
Instead of focusing commercial strategies on market share or product sales, companies need to develop a granular understanding on the issues that patients and physicians face, and concentrate their efforts on ... However, while the stakeholders at the
-
Immuno-oncology is fundamentally changing what value means, but how quickly can the pharma marketing, educational and service model change to reflect that?
very tailored information and insights that, just like the therapies in question, are personalised to the exact needs of the physician. ... solutions. Taking the long view, this could be seen as a very logical evolution of the pharma/physician
-
Cutting through the noise
Physicians want to:. Maintain knowledge of best practices or learn about new developments in their field. ... What would the physician value but currently misses? What could make the programme work seamlessly?
-
‘How is your day?’
These are the specialist physicians who prescribe them, and the patients and their families whose lives they have transformed. ... Physicians need to be more aware of rare diseases that may hide behind recurring issues that some patients have.
More from intelligence
Approximately 3 fully matching, plus 198 partially matching documents found.
Latest appointments
-
Dr Martin Rothman joins Sofinnova Partners
His new position at the firm will also see him take on a mentor role, as he will guide entrepreneurs and physicians launching clinical innovations. ... Commenting on the appointment, Antoine Papiernik, managing partner and chairman of Sofinnova Partners,
-
José Baselga joins BMS’ board of directors
Dr Baselga is currently the physician in chief at Memorial Sloan Kettering Cancer Center, where he is responsible for the management of patients care, enhancing and expanding programmes in clinical and ... Giovanni Caforia, chairman and chief executive
-
Dr Sotirios Stergiopoulos leaves Shire for Ipsen
Stergiopoulos, who has also previously served as director of medical affairs, oncology for Bayer, is a fellow at the American College of Physicians and a member of the Royal Society of
-
Sobi names Holly May VP of sales and marketing, US
May said: “I have been privileged to work in the rare disease field, leading commercial teams in providing education to patients, caregivers and physicians around important rare disease issues.
-
P/S/L appoints new MD for its research business Medefield
He said: “As Medefield continues to transform through innovation in sample data quality, driven by investment in its unique physician directory, it is an exciting time to be part of a
More from appointments
Approximately 0 fully matching, plus 56 partially matching documents found.
Latest from PMHub
-
More tell, less sell: HCP-centric comms
Accessed 22 May 2018. 2. Medscape. Physicians Experience Highest Suicide Rate of Any Profession. ... Physicians. Irvine, CA: 2017. 8. DRG Digital – Manhattan Research. ePharma Physician study.
-
Genetic counsellors: the new healthcare influencers?
Priorities for the future should include strategies to expand the genetic counsellor workforce and interventions to improve physicians’ skills in communication and cancer risk assessment.”. ... In the future, I hope pharma will have experts to
-
Mastering the precision medicine opportunity
This will impact the way physicians’ view testing, using tests to inform the treatment choice rather than confirm it (Figure 2). ... This sets out a clear need for treatment agnostic broad panel testing that provides physicians with a decision support
-
Bringing the NHS into the 21st century
Bringing the NHS into the 21st century. As the NHS celebrates its 70th birthday and a £20bn “ birthday gift” from the UK government, we find out how one company is delivering what the National Health Service really needs – a financially
-
Successful brands tell stories
An oncology tale. In 2017 Blue Latitude Health was asked to develop differentiated and convincing global messaging for physicians helping prostate cancer patients. ... The stories stood out and supported broader conversations, which gave a voice to
More from PMHub
Approximately 13 fully matching, plus 274 partially matching documents found.
Featured jobs
-
Account Manager
-
Negotiable
-
Sudler London - Account Director
-
Competitive
- Senior/ Market Access Consultant, UK, HOME BASED, £50-60K
-
Excellent package
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
- Science Writer, Healthcare Advertising Agency
-
£40, 000 - 45, 000 DOE benefits,
- Technical Manager – Developer and Commercial Excellence, Healthc...
-
Excellent package
-
Senior Training Manager - Surrey
-
Competitive Salary &Bonus
- Account Director or Senior Account Director
-
Salary TBC
- Senior Writer, Healthcare Advertising, London
-
Excellent package
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Leadership opportunity, Pricing & Market Access, UK, Substan...
-
Substantial six figure package
- Senior Medical Writer, MedComms Agency
-
Salary TBC
- Sudler London - Senior Medical Writer
-
Competitive
- Senior Strategist/ Planner, Healthcare Marketing, London
-
Excellent package
- Senior Medical Writer, MedComms Agency
-
£40 - 55, 000 according to skills and experience benefits
- Scientific Director – Medical Communications - New York or Remot...
-
$100000 - $150000
Subscribe to our email news alerts
- Lucid limbers up for second annual sports day
- Cello poaches Astellas' Taylor, Con Franklin joins Ketchum, Uptake Strategies expands
- Hanover Health launches award, Firstlight spins off healthcare arm and more
- J&J files ‘breakthrough’ bladder cancer drug in US
- Boehringer’s Corsico to be new GSK drug dev leader
- More tell, less sell: HCP-centric comms
PMHub
mXm Medical Communications
mXm Medical Communications meets the needs of pharmaceutical marketers and medics who require a highly experienced, bespoke service from their...
Latest intelligence
- PM Society Digital Awards – the power of together
- Our chief executive, Emma Statham, writes about the value of awards and the power of together....
- Seduce anyone in four simple steps
- You know the health of the global economy is dependent on our ability to seduce one another – don’t you? And you know that we need to be able to...
- What Would Jeremy Do? : Assessing the impact of a Corbyn-led Labour government
- GK Strategy are delighted to announce the launch our latest briefing paper entitled ‘What Would Jeremy Do? Assessing the impact of a Corbyn-led Labour government’....
Quick links
Infographics
